Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Multi-centre, Parallel Group Study to Compare the Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of Febuxostat Between Pediatric Patients (≥6<18 Years of Age) and Adults

NCT03605212 is registered in ClinicalTrials.gov with Menarini Group as lead sponsor.

NCT NCT03605212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03605212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Multi-centre, Parallel Group Study to Compare the Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of Febuxostat Between Pediatric Patients (≥6<18 Years of Age) and Adults
Lead sponsor
Menarini Group
Phase
Phase 1/2
Overall status
Terminated
Start date
February 27, 2017
Completion date
July 25, 2018
Enrollment
30 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

tumor lysis syndrome